E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/15/2013 in the Prospect News Bank Loan Daily.

Centene ups leverage cap, adds pricing tier to loan terms via Barclays

By Susanna Moon

Chicago, Feb. 15 - Centene Corp. amended its credit agreement Tuesday with Barclays Bank plc as administrative agent, according to an 8-K filing with the Securities and Exchange Commission.

The company amended some debt covenants to raise the maximum total debt-to-EBITDA ratio during the first three quarters of 2013 to provide for more borrowing availability, the filing noted.

The maximum total debt-to-EBITDA ratio is 2.75 times for the computation period ended Dec. 31, 3.85 times for the period ending March 31, 3.5 times for the period ending June 30, 3.25 times for the period ending Sept. 30, 2013 and 3 times as of Dec. 31, 2013 and thereafter.

The amendment also added an additional pricing tier, with pricing on the loans at Libor plus 225 basis points to 350 bps based on leverage.

Centene is a St. Louis-based health-care company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.